jstallworth on DSK7TPTVN1PROD with NOTICES

70238 Federal Register / Vol. 80, No. 219 / Friday, November 13, 2015 / Notices 
 


Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: 

Authority: 42 CFR 83.9–83.12. 

Pursuant to 42 CFR 83.12, the initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Battelle King Avenue. 

Location: Columbus, Ohio. 

Job Titles and/or Job Duties: All 

Atomic Weapons Employees who 

worked at the facility owned by the 

Battelle Laboratories at the King Avenue 

site in Columbus, Ohio, during the 

period from July 1, 1956 through 

December 31, 1970, for a number of 

work days aggregating at least 250 work 

days, occurring either solely under this 

employment or in combination with 

work days within the parameters 

established for one or more other classes 

of employees in the Special Exposure 

Cohort. 

Period of Employment: July 1, 1956 

through December 31, 1970. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2015–28905 Filed 11–12–15; 8:45 am] 

BILLING CODE 4163–19–P 

provided in our final rule of June 25, 

2007 (72 FR 34752) on the Current Good 

Manufacturing Practice in 

Manufacturing, Packaging, Labeling, or 

Holding Operations for Dietary 

Supplements, and factoring for a two 

percent annual growth rate), we 

calculate an annual disclosure burden of 

3.27 disclosures (labels) per firm. Last, 

we expect that firms prepare the 

required labeling for their products in a 

manner that takes into account at one 

time all information required to be 

disclosed and therefore believe that less 

than 0.2 hours (12 minutes) per product 

label would be expended to fulfill this 

requirement. 

In row 2 of Table 1 we estimate the 

total burden associated with the 

recommendation to include an 

explanatory statement on dietary 

supplement product labels letting 

consumers know the purpose of the 

domestic address or telephone number 

to be 1,112 hours. Based upon our 

knowledge of food and dietary 

supplement labeling, we estimate it 

would require less than 0.2 hours (12 

minutes) per product label to include 

such a statement. 

Dated: November 5, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–28788 Filed 11–12–15; 8:45 am] 

Agenda: IC Director reports and any other 

committee business. 

Place: National Institutes of Health, 

Building 31, 6th Floor, Conference Room 

6C6, 31 Center Drive, Bethesda, MD 20892 

Contact Person: Gretchen Wood, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–4272, woodgs@od.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

acd.od.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Decision To Evaluate a Petition To 

Designate a Class of Employees From 

the Battelle King Avenue Site in 

Columbus, Ohio, To Be Included in the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: NIOSH gives notice of a 

decision to evaluate a petition to 

designate a class of employees from the 

Battelle King Avenue site in Columbus, 

Ohio, to be included in the Special 

Exposure Cohort under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 1090 Tusculum 

Avenue, MS C–46, Cincinnati, OH 

45226–1938, Telephone 877–222–7570. 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Advisory Committee to the Director, 

National Institutes of Health. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Advisory Committee 

to the Director, National Institutes of Health. 

Date: December 10–11, 2015. 

Time: December 10, 2015, 9:00 a.m. to 5:00 

p.m. 

Agenda: NIH Director’s report and ACD 

Working Group reports. 

Place: National Institutes of Health, 

Building 31, 6th Floor, Conference Room 

6C6, 31 Center Drive, Bethesda, MD 20892. 

Time: December 11, 2015, 9:00 a.m. to 

Adjournment 

Dated: November 6, 2015. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–28797 Filed 11–12–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute On Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.